Clive Richardson (photo credit: via YouTube)
May 1, 2020 10:04 AM EDT
R&D

Tick sali­va-de­rived drug shows promise in mid-stage rare skin dis­ease study

Natalie Grover

Reporter

Sci­en­tists of­ten lean on na­ture to de­vel­op drugs, for in­stance, the decades-old an­ti­co­ag­u­lant war­farin is de­rived from a chem­i­cal found nat­u­ral­ly in sweet clover and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Up­dat­ed: Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force as CEO de­parts

In sur­prise move, FDA's No. 2 Bum­pus to leave agency at end of 2024

Ex­clu­sive: In­sitro makes head­way on the hard­er road, dis­cov­er­ing new ALS drug tar­get

No­vo Nordisk part­ners with Broad In­sti­tute spin­out Pho­tys af­ter the star­tup's lay­offs

Tessera gets up to $50M from the Gates Foun­da­tion; Tvar­di’s re­verse merg­er

A service from the Financial Times